Xtant Medical Holdings, Inc. (XTNT) Financial Statements (2024 and earlier)

Company Profile

Business Address 664 CRUISER LANE
BELGRADE, MT 59714
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments20,29818,2432,3415,2376,7972,856
Cash and cash equivalents20,29818,2432,3415,2376,7972,856
Restricted cash and investments209144    
Receivables10,8537,1546,88010,1249,99012,714
Inventory, net of allowances, customer advances and progress billings17,28517,94521,40816,10117,30122,229
Inventory17,28517,94521,40816,10117,30122,229
Other undisclosed current assets6738447367845891,706
Total current assets:49,31844,33031,36532,24634,67739,505
Noncurrent Assets
Inventory, Noncurrent      194
Operating lease, right-of-use asset1,3801,2581,6902,100
Property, plant and equipment5,7855,2124,3474,6957,1749,913
Intangible assets, net (including goodwill)3,5493,6053,6623,7203,77855,361
Goodwill3,2053,2053,2053,2053,20541,535
Intangible assets, net (excluding goodwill)34440045751557313,826
Other noncurrent assets197287402394793731
Total noncurrent assets:10,91110,36210,10110,90911,74566,200
TOTAL ASSETS:60,22954,69241,46643,15546,422105,705
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities8,9866,9648,4098,81311,61525,161
Accounts payable3,4902,6152,2892,1886,4659,315
Accrued liabilities5,4964,3496,1206,6255,15015,845
Debt2,3953,65116,817570426365
Derivative instruments and hedges, liabilities    710131
Due to related parties     160
Other undisclosed current liabilities3,837462423   
Total current liabilities:15,21811,07725,6499,39012,05125,818
Noncurrent Liabilities
Long-term debt and lease obligation9,86812,7321,30377,97078,14367,732
Long-term debt, excluding current maturities9,68711,787 76,24477,93967,109
Capital lease obligations204623
Finance lease, liability181103  
Liabilities, other than long-term debt972     
Operating lease, liability9728421,3031,726
Other undisclosed noncurrent liabilities  (842)(1,303)  70,853
Total noncurrent liabilities:10,84012,7321,30377,97078,143138,586
Total liabilities:26,05823,80926,95287,36090,194164,404
Equity
Equity, attributable to parent34,17130,88314,514(44,205)(43,772)(58,699)
Common stock      0
Additional paid in capital277,841266,068244,850179,061171,27386,247
Accumulated other comprehensive loss      
Accumulated deficit(243,670)(235,185)(230,336)(223,266)(215,045)(144,946)
Total equity:34,17130,88314,514(44,205)(43,772)(58,699)
TOTAL LIABILITIES AND EQUITY:60,22954,69241,46643,15546,422105,705

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues57,96955,26353,33764,68272,20382,612
Revenue, net82,612
Cost of revenue
(Cost of Goods and Services Sold)
(25,832)(22,773)(18,945)(22,166)(28,717)(32,511)
Gross profit:32,13732,49034,39242,51643,48650,101
Operating expenses(38,892)(36,344)(35,143)(44,769)(103,564)(87,935)
Operating loss:(6,755)(3,854)(751)(2,253)(60,078)(37,834)
Nonoperating income (expense)(1,661)(995)(5,976)(5,870)(10,021)(14,577)
Interest and debt expense(1,692)(995)(3,488)(1,534)(10,145)(14,705)
Loss from continuing operations before equity method investments, income taxes:(10,108)(5,844)(10,215)(9,657)(80,244)(67,116)
Other undisclosed income from continuing operations before income taxes1,6929953,4881,53410,14514,705
Income (loss) from continuing operations before income taxes:(8,416)(4,849)(6,727)(8,123)(70,099)(52,411)
Income tax expense (benefit)(69) (296)98  
Income (loss) from continuing operations:(8,485)(4,849)(7,023)(8,025)(70,099)(52,411)
Loss before gain (loss) on sale of properties:(4,849)(7,023)(8,025)(70,099)(52,411)
Net income (loss):(8,485)(4,849)(7,023)(8,025)(70,099)(52,411)
Other undisclosed net loss attributable to parent    (196)  
Net income (loss) available to common stockholders, diluted:(8,485)(4,849)(7,023)(8,221)(70,099)(52,411)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net income (loss):(8,485)(4,849)(7,023)(8,025)(70,099)(52,411)
Comprehensive income (loss):(8,485)(4,849)(7,023)(8,025)(70,099)(52,411)
Other undisclosed comprehensive loss, net of tax, attributable to parent      
Comprehensive income (loss), net of tax, attributable to parent:(8,485)(4,849)(7,023)(8,025)(70,099)(52,411)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: